Literature DB >> 19209239

Activation of the cholinergic antiinflammatory pathway reduces ricin-induced mortality and organ failure in mice.

Jon G Mabley1, Pal Pacher, Csaba Szabo.   

Abstract

Exposure to ricin, either by accident through ingestion of castor oil plant seeds or intentionally through its use as a bioweapon, invariably leads to multiple organ damage and death. Currently there is only a vaccine in advanced development to ricin, but no other antidote. Ricin causes systemic inflammation with increased proinflammatory cytokine release and subsequent multiple organ failure, particularly kidney and liver dysfunction. Activation of the cholinergic antiinflammatory pathway, specifically through the alpha7 nicotinic acetylcholine receptor (either indirectly through vagus nerve stimulation or directly through nicotine treatment) reduces proinflammatory gene expression. This activation also increases release of proinflammatory chemokines and cytokines, and has proven effective in a variety of inflammatory diseases. The aim of this study was to investigate whether nicotine treatment protected against ricin toxicity in mice. Male Balb/c mice exposed to ricin had increased serum levels of the inflammatory cytokine tumor necrosis factor-alpha and markers of both kidney (blood urea nitrogen, creatine) and liver (alanine tranaminase) dysfunction, with a subsequent increase in mortality. Nicotine administration 2 h after ricin injection significantly delayed and reduced ricin-induced mortality, an effect coupled with reduced serum levels of tumor necrosis factor-alpha and markers of kidney and liver dysfunction. Both the kidney and liver had markedly increased cellular oxidative stress following ricin exposure, an effect attenuated by nicotine administration. In conclusion, these data demonstrate that in cases of ricin poisoning, activation of the cholinergic antiinflammatory pathway may prove beneficial by reducing organ damage, delaying mortality, and allowing for a greater chance of survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19209239      PMCID: PMC2637759          DOI: 10.2119/molmed.2008.00105

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  51 in total

1.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

2.  Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia.

Authors:  Mauricio Rosas-Ballina; Mahendar Ochani; William R Parrish; Kanta Ochani; Yael T Harris; Jared M Huston; Sangeeta Chavan; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

3.  Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats.

Authors:  Xiao Su; Jae Woo Lee; Zachary A Matthay; Gabe Mednick; Tokujiro Uchida; Xiaohui Fang; Naveen Gupta; Michael A Matthay
Journal:  Am J Respir Cell Mol Biol       Date:  2007-04-12       Impact factor: 6.914

4.  Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.

Authors:  William R Parrish; Mauricio Rosas-Ballina; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Li-Hong Yang; LaQueta Hudson; Xinchun Lin; Nirav Patel; Sarah M Johnson; Sangeeta Chavan; Richard S Goldstein; Christopher J Czura; Edmund J Miller; Yousef Al-Abed; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

5.  Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.

Authors:  Stefan Hofer; Christoph Eisenbach; Ivan K Lukic; Lutz Schneider; Konrad Bode; Martina Brueckmann; Sven Mautner; Moritz N Wente; Jens Encke; Jens Werner; Alexander H Dalpke; Wolfgang Stremmel; Peter P Nawroth; Eike Martin; Peter H Krammer; Angelika Bierhaus; Markus A Weigand
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

Review 6.  From CNI-1493 to the immunological homunculus: physiology of the inflammatory reflex.

Authors:  Stacey L Oke; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2007-12-07       Impact factor: 4.962

7.  Double-stranded RNA-activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, Shiga toxin 1, and ricin in monocytes.

Authors:  Jennifer S Gray; Hee Kyong Bae; James C B Li; Allan S Lau; James J Pestka
Journal:  Toxicol Sci       Date:  2008-07-03       Impact factor: 4.849

8.  The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor.

Authors:  Tetsuya Hiramoto; Yoichi Chida; Junko Sonoda; Kazufumi Yoshihara; Nobuyuki Sudo; Chiharu Kubo
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

9.  Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

Authors:  Valentin A Pavlov; William R Parrish; Mauricio Rosas-Ballina; Mahendar Ochani; Margot Puerta; Kanta Ochani; Sangeeta Chavan; Yousef Al-Abed; Kevin J Tracey
Journal:  Brain Behav Immun       Date:  2008-06-27       Impact factor: 7.217

10.  Post-exposure targeting of specific epitopes on ricin toxin abrogates toxin-induced hypoglycemia, hepatic injury, and lethality in a mouse model.

Authors:  James K Roche; Matthew K Stone; Lisa K Gross; Matthew Lindner; Regina Seaner; Seth H Pincus; Tom G Obrig
Journal:  Lab Invest       Date:  2008-09-08       Impact factor: 5.662

View more
  9 in total

1.  Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling.

Authors:  Meghan L Lindauer; John Wong; Yoichiro Iwakura; Bruce E Magun
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

2.  Nicotine exerts an anti-inflammatory effect in a murine model of acute lung injury.

Authors:  Jon Mabley; Sevelanne Gordon; Pal Pacher
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

3.  Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication.

Authors:  Praveena S Marconescu; Joan E Smallshaw; Laurentiu M Pop; Stephen L Ruback; Ellen S Vitetta
Journal:  Vaccine       Date:  2010-06-01       Impact factor: 3.641

4.  Enhanced parasympathetic cholinergic activity with galantamine inhibited lipid-induced oxidative stress in obese African Americans.

Authors:  Dena Parsa; Luul A Aden; Ashley Pitzer; Tan Ding; Chang Yu; Andre Diedrich; Ginger L Milne; Annet Kirabo; Cyndya A Shibao
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

5.  γ-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism.

Authors:  P A Ferchmin; Dinely Pérez; William Castro Alvarez; Mario A Penzo; Héctor M Maldonado; Vesna A Eterovic
Journal:  J Neurosci Res       Date:  2012-12-26       Impact factor: 4.164

Review 6.  Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders".

Authors:  Koji Hori; Kimiko Konishi; Misa Hosoi; Hiroi Tomioka; Masayuki Tani; Yuka Kitajima; Mitsugu Hachisu
Journal:  Parkinsons Dis       Date:  2016-09-22

Review 7.  Fluoride Exposure Induces Inhibition of Sodium-and Potassium-Activated Adenosine Triphosphatase (Na+, K+-ATPase) Enzyme Activity: Molecular Mechanisms and Implications for Public Health.

Authors:  Declan Timothy Waugh
Journal:  Int J Environ Res Public Health       Date:  2019-04-21       Impact factor: 3.390

Review 8.  Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects.

Authors:  Yoav Gal; Ohad Mazor; Reut Falach; Anita Sapoznikov; Chanoch Kronman; Tamar Sabo
Journal:  Toxins (Basel)       Date:  2017-10-03       Impact factor: 4.546

9.  Production, Characterisation and Testing of an Ovine Antitoxin against Ricin; Efficacy, Potency and Mechanisms of Action.

Authors:  Sarah J C Whitfield; Gareth D Griffiths; Dominic C Jenner; Robert J Gwyther; Fiona M Stahl; Lucy J Cork; Jane L Holley; A Christopher Green; Graeme C Clark
Journal:  Toxins (Basel)       Date:  2017-10-18       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.